Recruiting PHASE4 Chronic Neck Pain

New treatment option for Chronic Neck Pain

Official title Phrenic Nerve Infiltration in Neck Pain

ClinicalTrials.gov ID: NCT05605639

What this study is testing

What is Bupivacaine?

Bupivacaine is an investigational medicine, being studied as a potential treatment for chronic neck pain.

Also referred to as Bupivacaine B. Braun 2.5 mg/ml.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
Neck pain frequently present comorbidities in peridiaphragmatic organs. The innervation of these organs include the phrenic nerve.
  • Phase 4: studies an already-approved treatment
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 64

You may be able to join if

  • Over 18 and under 64 years old
  • Patients attending to the physician or physical therapist with a main complaint of neck pain
  • Presentation of any peridiaphragmatic visceral disorder.
  • That the subject agrees to participate in the project by signing the informed consent.

You likely can't join if

  • Illness of neurological, traumatic, oncological, infectious or rheumatic (fibromyalgia, ankylosing spondylitis...) origin.
  • Uncooperative subject.
  • Severe psychiatric illness.
  • Loss of Cognitive Ability.
  • Contraindication to infiltration of the phrenic nerve.
  • History of head, spinal or upper limb surgery
See the full eligibility criteria
Who can join
  • Over 18 and under 64 years old
  • Patients attending to the physician or physical therapist with a main complaint of neck pain
  • Presentation of any peridiaphragmatic visceral disorder.
  • That the subject agrees to participate in the project by signing the informed consent.
What rules you out
  • Illness of neurological, traumatic, oncological, infectious or rheumatic (fibromyalgia, ankylosing spondylitis...) origin.
  • Uncooperative subject.
  • Severe psychiatric illness.
  • Loss of Cognitive Ability.
  • Contraindication to infiltration of the phrenic nerve.
  • History of head, spinal or upper limb surgery
  • History of infiltration for the neck pain in the previous 3 months
  • History of physical therapy for the neck pain in the previous 30 days

The study team makes the final eligibility decision.

Where it's taking place

  • Dos Hermanas, Seville, Spain
  • Seville, Spain

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Dos Hermanas, Seville, Spain; Seville, Spain. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.